The European Patent Office had revised a patent granted to Edinburgh University and the biotech firm Stem Cell Services to remove the possibility that it could cover a method of cloning humans.
According to Reuters, the patent office has admitted that a reference in the patent to human cells had been missed by officials during the checking procedure.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.